Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Department of Laboratory Animal Medicine, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.01818-18. Print 2019 Mar 15.
Middle East respiratory syndrome coronavirus (MERS-CoV) infection can manifest as a mild illness, acute respiratory distress, organ failure, or death. Several animal models have been established to study disease pathogenesis and to develop vaccines and therapeutic agents. Here, we developed transgenic (Tg) mice on a C57BL/6 background; these mice expressed human CD26/dipeptidyl peptidase 4 (hDPP4), a functional receptor for MERS-CoV, under the control of an endogenous hDPP4 promoter. We then characterized this mouse model of MERS-CoV. The expression profile of hDPP4 in these mice was almost equivalent to that in human tissues, including kidney and lung; however, hDPP4 was overexpressed in murine CD3-positive cells within peripheral blood and lymphoid tissues. Intranasal inoculation of young and adult Tg mice with MERS-CoV led to infection of the lower respiratory tract and pathological evidence of acute multifocal interstitial pneumonia within 7 days, with only transient loss of body weight. However, the immunopathology in young and adult Tg mice was different. On day 5 or 7 postinoculation, lungs of adult Tg mice contained higher levels of proinflammatory cytokines and chemokines associated with migration of macrophages. These results suggest that the immunopathology of MERS-CoV infection in the Tg mouse is age dependent. The mouse model described here will increase our understanding of disease pathogenesis and host mediators that protect against MERS-CoV infection. Middle East respiratory syndrome coronavirus (MERS-CoV) infections are endemic in the Middle East and a threat to public health worldwide. Rodents are not susceptible to the virus because they do not express functional receptors; therefore, we generated a new animal model of MERS-CoV infection based on transgenic mice expressing human DPP4 (hDPP4). The pattern of hDPP4 expression in this model was similar to that in human tissues (except lymphoid tissue). In addition, MERS-CoV was limited to the respiratory tract. Here, we focused on host factors involved in immunopathology in MERS-CoV infection and clarified differences in antiviral immune responses between young and adult transgenic mice. This new small-animal model could contribute to more in-depth study of the pathology of MERS-CoV infection and aid development of suitable treatments.
中东呼吸综合征冠状病毒(MERS-CoV)感染可表现为轻症、急性呼吸窘迫、器官衰竭或死亡。已建立多种动物模型来研究疾病发病机制,并开发疫苗和治疗药物。在这里,我们在 C57BL/6 背景下建立了转基因(Tg)小鼠;这些小鼠在人源二肽基肽酶 4(hDPP4)内源性启动子的控制下表达功能性 MERS-CoV 受体 hDPP4。然后,我们对这种 MERS-CoV 小鼠模型进行了特征描述。这些小鼠中 hDPP4 的表达谱与包括肾脏和肺部在内的人类组织几乎相当;然而,hDPP4 在周围血液和淋巴组织中的 CD3 阳性细胞中过度表达。年轻和成年 Tg 小鼠经鼻腔接种 MERS-CoV 后,在 7 天内感染下呼吸道,并出现急性多灶性间质性肺炎的病理证据,仅出现短暂的体重减轻。然而,年轻和成年 Tg 小鼠的免疫病理学不同。在接种后第 5 或 7 天,成年 Tg 小鼠的肺部含有与巨噬细胞迁移相关的更高水平的促炎细胞因子和趋化因子。这些结果表明,Tg 小鼠中 MERS-CoV 感染的免疫病理学是年龄依赖性的。本文描述的小鼠模型将增加我们对疾病发病机制和宿主介质的理解,这些介质可预防 MERS-CoV 感染。中东呼吸综合征冠状病毒(MERS-CoV)感染在中东流行,对全球公共卫生构成威胁。由于啮齿动物不表达功能性受体,因此它们不易感染该病毒;因此,我们基于表达人源二肽基肽酶 4(hDPP4)的转基因小鼠,生成了一种新的 MERS-CoV 感染动物模型。该模型中 hDPP4 的表达模式与人类组织相似(除了淋巴组织)。此外,MERS-CoV 局限于呼吸道。在这里,我们重点研究了 MERS-CoV 感染中涉及免疫病理学的宿主因素,并阐明了年轻和成年转基因小鼠之间抗病毒免疫反应的差异。这种新的小动物模型有助于更深入地研究 MERS-CoV 感染的病理学,并有助于开发合适的治疗方法。